SEC Form 4 · accession 0001192482-17-000128
Tabula Rasa HealthCare, Inc. · TRHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Glen R Bressner
Director · 10% Owner
Period of report
May 17, 2017
Accepted (ET)
May 22, 2017 · 3:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 17, 2017 | P | 5,191 | $11.95 | A | 18,256 | D | |
| Common StockF2 | May 18, 2017 | P | 2,309 | $11.98 | A | 20,565 | D | |
| Common Stock | holding | — | — | — | 1,914,078 | I | By: Originate Growth Fund 1Q LP | |
| Common Stock | holding | — | — | — | 866,789 | I | By: Originate Growth Fund 1A LP | |
| Common Stock | holding | — | — | — | 1,000 | I | By: Son |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.90 to $11.98, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.96 to $11.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.